Logo image of JUVE.MI

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) Stock Fundamental Analysis

BIT:JUVE - Borsa Italiana Milan - IT0005572778 - Common Stock - Currency: EUR

2.354  -0.04 (-1.63%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to JUVE. JUVE was compared to 44 industry peers in the Entertainment industry. JUVE has a bad profitability rating. Also its financial health evaluation is rather negative. JUVE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

JUVE had negative earnings in the past year.
JUVE had a negative operating cash flow in the past year.
In the past 5 years JUVE always reported negative net income.
JUVE had negative operating cash flow in 4 of the past 5 years.
JUVE.MI Yearly Net Income VS EBIT VS OCF VS FCFJUVE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

JUVE has a Return On Assets of -29.34%. This is amonst the worse of the industry: JUVE underperforms 92.50% of its industry peers.
JUVE's Return On Equity of -495.63% is on the low side compared to the rest of the industry. JUVE is outperformed by 82.50% of its industry peers.
Industry RankSector Rank
ROA -29.34%
ROE -495.63%
ROIC N/A
ROA(3y)-23.28%
ROA(5y)-20.49%
ROE(3y)-311.57%
ROE(5y)-718.42%
ROIC(3y)N/A
ROIC(5y)N/A
JUVE.MI Yearly ROA, ROE, ROICJUVE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

JUVE's Gross Margin of 89.06% is fine compared to the rest of the industry. JUVE outperforms 72.50% of its industry peers.
In the last couple of years the Gross Margin of JUVE has remained more or less at the same level.
JUVE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y-0.68%
JUVE.MI Yearly Profit, Operating, Gross MarginsJUVE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

JUVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
JUVE has more shares outstanding than it did 1 year ago.
JUVE has less shares outstanding than it did 5 years ago.
JUVE has a better debt/assets ratio than last year.
JUVE.MI Yearly Shares OutstandingJUVE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
JUVE.MI Yearly Total Debt VS Total AssetsJUVE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.19, we must say that JUVE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of JUVE (-0.19) is worse than 75.00% of its industry peers.
JUVE has a Debt/Equity ratio of 6.68. This is a high value indicating a heavy dependency on external financing.
JUVE has a Debt to Equity ratio of 6.68. This is in the lower half of the industry: JUVE underperforms 77.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.68
Debt/FCF N/A
Altman-Z -0.19
ROIC/WACCN/A
WACC7.02%
JUVE.MI Yearly LT Debt VS Equity VS FCFJUVE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

JUVE has a Current Ratio of 0.44. This is a bad value and indicates that JUVE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of JUVE (0.44) is worse than 80.00% of its industry peers.
A Quick Ratio of 0.43 indicates that JUVE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.43, JUVE is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.43
JUVE.MI Yearly Current Assets VS Current LiabilitesJUVE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

JUVE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.88%.
The Revenue for JUVE has decreased by -19.28% in the past year. This is quite bad
Measured over the past years, JUVE shows a decrease in Revenue. The Revenue has been decreasing by -4.35% on average per year.
EPS 1Y (TTM)-69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.29%
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-8.21%
Revenue growth 5Y-4.35%
Sales Q2Q%-10.75%

3.2 Future

JUVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.11% yearly.
Based on estimates for the next years, JUVE will show a quite strong growth in Revenue. The Revenue will grow by 9.00% on average per year.
EPS Next Y91.19%
EPS Next 2Y38.75%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue Next Year36.62%
Revenue Next 2Y16.42%
Revenue Next 3Y11.38%
Revenue Next 5Y9%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JUVE.MI Yearly Revenue VS EstimatesJUVE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M
JUVE.MI Yearly EPS VS EstimatesJUVE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JUVE. In the last year negative earnings were reported.
Also next year JUVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JUVE.MI Price Earnings VS Forward Price EarningsJUVE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JUVE.MI Per share dataJUVE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as JUVE's earnings are expected to grow with 26.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.75%
EPS Next 3Y26.11%

More info and screens

0

5. Dividend

5.1 Amount

JUVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JUVENTUS FOOTBALL CLUB SPA

BIT:JUVE (2/5/2025, 2:42:24 PM)

2.354

-0.04 (-1.63%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-04 2024-10-04/amc
Earnings (Next)N/A N/A
Inst Owners9.28%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap892.45M
Analysts40
Price Target2.35 (-0.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)15%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)48.14%
EPS NY rev (3m)67.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.68%
Revenue NY rev (3m)8.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.4
P/FCF N/A
P/OCF N/A
P/B 22.2
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.98
BVpS0.11
TBVpS-0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.34%
ROE -495.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.06%
FCFM N/A
ROA(3y)-23.28%
ROA(5y)-20.49%
ROE(3y)-311.57%
ROE(5y)-718.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y-0.68%
F-Score2
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 6.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 68.62%
Cap/Sales 28.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.43
Altman-Z -0.19
F-Score2
WACC7.02%
ROIC/WACCN/A
Cap/Depr(3y)94.78%
Cap/Depr(5y)102.09%
Cap/Sales(3y)38.62%
Cap/Sales(5y)46.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.29%
EPS Next Y91.19%
EPS Next 2Y38.75%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-8.21%
Revenue growth 5Y-4.35%
Sales Q2Q%-10.75%
Revenue Next Year36.62%
Revenue Next 2Y16.42%
Revenue Next 3Y11.38%
Revenue Next 5Y9%
EBIT growth 1Y-46.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year173.21%
EBIT Next 3Y39.88%
EBIT Next 5Y24.33%
FCF growth 1Y25.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.98%
OCF growth 3YN/A
OCF growth 5YN/A